Gulbenkian Institute For Molecular Medicine
Clinical trials sponsored by Gulbenkian Institute For Molecular Medicine, explained in plain language.
-
Gut bacteria clues could lead to simple cancer test
Diagnosis Recruiting nowThis study is looking at whether analyzing the bacteria in a person's stool can help detect colorectal cancer earlier, especially in people under 50 who are not routinely screened. Researchers will collect stool samples and diet information from 400 adults in Portugal recently di…
Sponsor: Gulbenkian Institute for Molecular Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Scientists probe Gut-Hormone link in Women's aging
Knowledge-focused Recruiting nowThe AGEWISE study is observing 300 healthy women aged 40 to 64 in Portugal to understand how gut bacteria change with hormones during menopause. Participants provide stool and blood samples and answer health and diet questionnaires. Researchers hope to uncover connections between…
Sponsor: Gulbenkian Institute for Molecular Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Gut bacteria could hold key to better colon cancer detection
Knowledge-focused Recruiting nowThis study aims to improve early detection of colorectal cancer by analyzing gut bacteria in stool samples from 30,000 people in Portugal aged 40-74. Researchers will compare the microbiome of healthy individuals with those who have precancerous polyps or cancer, looking for uniq…
Sponsor: Gulbenkian Institute for Molecular Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC